Kensey Nash to Participate in the Friedman Billings Ramsey 12th Annual Spring Investor Conference

Friday, May 23, 2008 General News J E 4
EXTON, Pa., May 23 Kensey Nash Corporation(Nasdaq: KNSY) is scheduled to present at the FBR 12th Annual Spring InvestorConference at the Grand Hyatt New York Hotel in New York City on Wednesday,May 28, 2008.

Douglas G. Evans, Kensey Nash's COO, will deliver the Company'spresentation, beginning at approximately 12:50 p.m. (EDT). To hear the livewebcast of the Kensey Nash presentation at the FBR conference, go to and access the conference link. Thepresentation materials will be available on the company's website( beginning at 12:50 p.m. (EDT) on Wednesday, May28, 2008.

About Kensey Nash Corporation. Kensey Nash Corporation is a leadingmedical technology company providing innovative solutions and technologies fora wide range of medical procedures. The Company provides an extensive rangeof products into multiple medical markets, primarily in the sports medicine,spine, and endovascular markets. Many of the products are based on theCompany's significant expertise in the design, development, manufacturing andprocessing of absorbable biomaterials, which has led to partnerships tocommercialize technologies. Kensey Nash has also developed and commercializeda series of innovative endovascular products and recently announced the saleof this product line to Spectranetics, Inc. In conjunction with the saletransaction, the Company will continue to manufacture and develop theseproducts for Spectranetics for a period of time. The Company is known as apioneer in the field of arterial puncture closure, as the inventor anddeveloper of the Angio-Seal(TM) Vascular Closure Device, which is licensed toSt. Jude Medical, Inc.

SOURCE Kensey Nash Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Dance Trance Fitness(TM) and SyncLive(TM) Broadcas...
Cardium Therapeutics Announces Annual Meeting of S...